Location History:
- Naperville, IL (US) (2009 - 2011)
- Rochester, MN (US) (2019)
Company Filing History:
Years Active: 2009-2019
Title: Alicia Algeciras-Schimnich: Innovating Cervical Cancer Detection
Introduction
Alicia Algeciras-Schimnich is an accomplished inventor based in Naperville, IL, known for her significant contributions to the field of medical diagnostics. With a total of three patents to her name, she has shown a strong commitment to improving cervical cancer detection and the associated methodologies.
Latest Patents
Alicia's latest patent focuses on the "Detection of high grade dysplasia in cervical cells." The methods described involve using probes and probe sets to detect high-grade dysplasia and carcinoma in cervical cells. This innovative approach includes hybridizing chromosomal probes to biological samples obtained from subjects. By detecting the hybridization pattern, it becomes possible to determine whether the subject has high-grade dysplasia or carcinoma. Furthermore, her methods include preliminary screening for specific markers associated with cancer risk, prioritizing the identification of HPV-infected cells using an HPV probe mixture.
Career Highlights
Throughout her career, Alicia has made a substantial impact while working with reputable organizations such as Vysis, Inc. and Abbott Molecular Inc. Her experience in these companies not only showcases her expertise but also her commitment to research and development in the field of molecular diagnostics.
Collaborations
Alicia has collaborated with notable coworkers including Irina A. Sokolova and Steven A. Seelig. These partnerships reflect a collaborative spirit in the medical research community, contributing to advancements in the detection and understanding of cervical cancer risks.
Conclusion
Alicia Algeciras-Schimnich's innovative work in the detection of cervical cancer exemplifies her dedication to enhancing healthcare outcomes. With her patented methods paving the way for improved diagnostics, she stands as a significant figure in medical research, demonstrating the impact of invention on public health. Her journey highlights the importance of collaboration and innovation in tackling critical health challenges.